Suchergebnisse - (Person:"Sheng, Jifang")

PubPharm (11)

1

Combining Hepatitis B Virus RNA and Hepatitis B Core-Related Antigen : Guidance for Safely Stopping Nucleos(t)ide Analogues in Hepatitis B e Antigen-Positive Patients With Chronic Hepatitis B

enthalten in: The Journal of infectious diseases | 2020

von Fan, R. | Peng, J. | Xie, Q. | +25

2

Association Between Negative Results From Tests for HBV DNA and RNA and Durability of Response After Discontinuation of Nucles(t)ide Analogue Therapy

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2020

von Fan, R. | Zhou, B. | Xu, M. | +27

CommentIn: Clin Gastroenterol Hepatol. 2020 Mar;18(3):551-552. - PMID 31473358

3

Sustained serological and complete responses in HBeAg-positive patients treated with Peginterferon alfa-2b : a 6-year long-term follow-up of a multicenter, randomized, controlled trial in China

enthalten in: BMC gastroenterology | 2019

von Sun, J. | Ding, H. | Chen, G. | +21

4

HBsAg and HBeAg in the prediction of a clinical response to peginterferon α-2b therapy in Chinese HBeAg-positive patients

enthalten in: Virology journal | 2016

von Yang, S. | Xing, H. | Wang, Y. | +27

5

Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues

enthalten in: Gut | 2016

von Fan, R. | Sun, J. | Yuan, Q. | +29

6

Associations between hepatitis B virus basal core promoter/pre-core region mutations and the risk of acute-on-chronic liver failure : a meta-analysis

enthalten in: Virology journal | 2015

von Hu, F. | Bi, S. | Yan, H. | +2

7

Randomized, three-arm study to optimize lamivudine efficacy in hepatitis B e antigen-positive chronic hepatitis B patients

enthalten in: Journal of gastroenterology and hepatology | 2015

von Liang, X. | Cheng, J. | Sun, Y. | +26

8

A randomized, open-label clinical study of combined pegylated interferon Alfa-2a (40KD) and entecavir treatment for hepatitis B "e" antigen-positive chronic hepatitis B

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2014

von Xie, Q. | Zhou, H. | Bai, X. | +7

9

Peginterferon alfa-2b in the treatment of Chinese patients with HBeAg-positive chronic hepatitis B : a randomized trial

enthalten in: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology | 2014

von Cheng, J. | Wang, Y. | Hou, J. | +26

10

Switching from entecavir to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B : a randomised open-label trial (OSST trial)

enthalten in: Journal of hepatology | 2014

von Ning, Q. | Han, M. | Sun, Y. | +6

CommentIn: J Hepatol. 2015 Jan;62(1):240-1. - PMID 25308175